Potency testing

Potency assays are used to measure the biological activity and effectiveness of a drug product, particularly biologic drugs like vaccines, monoclonal antibodies, and gene therapies. The primary goal of a potency assay is to ensure that the drug performs its intended function at the required level of activity. These tests can be used for product evaluation as early stages of drug development (screening) or submitted to regulatory authorities as part of Chemistry, Manufacturing and Controls (CMC).

As mentioned, potency assays are crucial since they are used to confirm that the biologic product can achieve the desired therapeutic effect. For this reason, regulatory agencies such as the FDA (Food and Drug Administration) and EMA (European Medicines Agency) require potency assays as part of the approval process for biologics. These tests demonstrate that the product is consistently effective and safe.

A quality control specialist, Clean Cells has developed and proposed a large panel of potency tests including biological assays (bioassays or cell-based assays) and Binding assays (ELISA).

All these tests are fully validated according to ICHQ2R2 guidelines and cGMP standards. They can be used either for screening (early stages) or for release testing of a final drug product.

Clean Cells’ offer encompasses:

  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) assay
  • CDC assay (Complement-Dependent Cytotoxicity)
  • Telomerase activity testing by NAT approach
  • Cytokine expression
  • Phenotype profile determination using Flow cytometry tests.
Potency

Thanks to our analytical development department and our expertise, we can develop and/or validate new biological assays to fulfil the specific needs of your project. Do not hesitate to email us for additional information on existing capabilities and method development.

"*" indicates required fields